DSGN (DSGN) Stock Price & Analysis
DSGN (DSGN) rose 0.73% to USD 15.14 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
DSGN last closed at USD 15.14; the session ranged USD 14.96–15.35 on volume of 256,617 shares. Market capitalization is —, with a 52-week range of USD 5.28–17.25 (NMS). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 15.14 |
|---|---|
| Change | ▲ 0.73% (up) |
| Previous Close | USD 15.14 |
| Open | USD 15.14 |
| Day Range | USD 14.96 – 15.35 |
| 52-Week Range | USD 5.28 – 17.25 |
| Volume | 256,617 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (DSGN)
Nexqual's technical model rates DSGN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.17 (neutral) |
| vs SMA50 | Above (USD 14.07) |
| MACD | 0.43 (positive) |
From DSGN's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| IMCR | Immunocore Holdings plc | USD 36.13 | ▼ 3.32% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 13.84 | ▼ 2.67% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.92 | ▼ 4.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.